The symptoms of Schizophrenia can impact the daily lives of both those affected and their loved ones. The Michigan Clinical Research Institute is a site for multiple research trials which aim to reduce symptoms associated with Schizophrenia. Specifically, the current trials test medications for improving cognitive function and preventing relapse. For more information on these trials, click here, here, and here. We are also seeking participants for a study that works to prevent schizophrenia from developing in its early stages. For more information on this trial, click here.
What to Expect?
First, a consultation visit to assess eligibility and ensure your interest in participation.
Participation will include taking a medication on a daily basis and regular site study visits.
Study visits consist of psychiatric and physical evaluations, along with vital assessments such as EKG, blood pressure, and laboratory tests.
Medication and care related to research will not be charged.
Families will be compensated for their time and travel.
To learn more about participation, please call (734) 834 - 8954.
*Disclosure: Dr. Rajarethinam, the Principal Investigator, conducts contract research for various pharmaceutical companies, including: Johnson & Johnson, Neurocrine, Otsuka, Astellas, Jansson, and a variety of others. He also participates in promotional meetings for Neurocrine Sciences.